RavenQuest BioMed Inc.
RVVQF
$0.00
$0.000.00%
| 07/31/2019 | 04/30/2019 | 01/31/2019 | 10/31/2018 | 07/31/2018 | |
|---|---|---|---|---|---|
| Net Income | 2.23% | -0.33% | 86.31% | -617.31% | 9.44% |
| Total Depreciation and Amortization | 67.60% | -37.61% | -58.99% | 4,851.93% | 819.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.79% | 32.90% | -92.57% | 1,483.93% | 49.77% |
| Change in Net Operating Assets | -459.34% | -94.72% | -32.72% | 192.96% | -172.40% |
| Cash from Operations | -65.40% | -157.18% | 1,094.70% | 97.59% | -44.25% |
| Capital Expenditure | 56.30% | 10.33% | 50.86% | 38.47% | -65.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 56.30% | 10.33% | 58.67% | 26.85% | 71.09% |
| Total Debt Issued | -- | -100.00% | 261.62% | -- | -100.00% |
| Total Debt Repaid | -- | 100.00% | 0.00% | -- | -- |
| Issuance of Common Stock | -9.08% | 2,746.67% | -97.77% | -47.61% | -29.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,794.62% | 93.09% | -1,325.19% | 90.45% | 45.30% |
| Cash from Financing | -43.35% | 265.58% | -76.64% | -59.84% | -70.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -259.92% | -41.33% | 158.07% | 74.34% | -220.86% |
